CoChat

Studies of pancreatic alpha cell function in normal and diabetic subjects

Open access
Unger, Roger H., Aguilar-Parada, E., Müller, Walter A., Eisentraut, Anna M. · 1970 · Journal of Clinical Investigation

The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.

Abstract

The development of a glucagon radioimmunoassay with a relatively high degree of specificity for pancreatic glucagon made possible studies of alpha cell function in healthy nondiabetic subjects and in patients with diabetes mellitus. In the former group mean fasting plasma glucagon averaged 108 mumug/ml (SEM +/-10). In 12 juvenile-type diabetics fasting glucagon averaged 110 (+/-9) and in 33 adult-type diabetics the average was 114 (+/-8). The diabetic averages did not differ significantly from the nondiabetic subjects; however, when hyperglycemia was induced by glucose infusion in the nondiabetic subjects so as to simulate the fasting hyperglycemia of the diabetics, mean glucagon fell to 57 mumug (+/-8), which was significantly below the diabetic mean. In 28 healthy subjects the infusion of arginine elicited a rise in glucagon of at least 100 mumug/ml with a peak level averaging 331 mumug/ml (+/-22) at 40 min. This response to arginine was diminished but not abolished during hyperglycemia induced by simultaneous glucose infusion. In everyone of 45 diabetic subjects tested the infusion of arginine elicited a rise in glucagon of at least 140 mumug/ml to levels significantly greater than in nondiabetics. The peak glucagon level in juvenile-type diabetics averaged 458 mumug/ml (SEM +/-36) and in adult-type diabetics averaged 452 mumug/ml (SEM +/-38). The glucagon response to arginine was unrelated to duration of diabetes, to body weight, type of diabetic treatment, or to other known factors. Marked hyperresponsiveness of glucagon to arginine infusion was observed in two patients with advanced Kimmelsteil-Wilson disease. Glucagon levels were markedly elevated in certain patients with severe diabetic ketoacidosis before treatment with insulin. The findings suggest that alpha cell function is inappropriately increased in diabetes mellitus and could play a significant role in the diabetic syndrome.

Overview

Integrity signals

Registry

Crossref · 10.1172/jci106297

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Show all 27 references

Cited by

See all 841

Metadata

Authors
Unger, R. H., Aguilar-Parada, E., Müller, W. A., & Eisentraut, A. M.
Affiliations
American Society for Clinical Investigation (US)
Venue
Journal of Clinical Investigation
Published
1970-04-01
Volume
49
Issue
4
Pages
837-848
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2146415791
Cited by
837
References
28
Citations by year
2026: 10 · 2025: 10 · 2024: 18 · 2023: 14 · 2022: 8 · 2021: 11 · 2020: 14 · 2019: 18 · 2018: 24 · 2017: 12 · 2016: 15 · 2015: 16 · 2014: 15 · 2013: 4 · 2012: 12
FWCI
83.31
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Eli Lilly and Company
  • Pfizer
  • National Institutes of Health
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
alpha cells, glucagon secretion, diabetes mellitus, arginine stimulation, hyperglycemia, diabetic ketoacidosis, type 1 diabetes, type 2 diabetes
MeSH terms
Adolescent, Adult, Arginine, Body Weight, Child, Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetic Nephropathies, Fasting, Glucagon, Glucose, Humans, Hyperglycemia, Insulin, Middle Aged, Pancreas, Radioimmunoassay, Diabetic Ketoacidosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Studies of pancreatic alpha cell function in normal and diabetic subjects. https://app.cochat.ai/papers/10.1172/jci106297
The paper
Unger, R. H., Aguilar-Parada, E., Müller, W. A., & Eisentraut, A. M. (1970). Studies of pancreatic alpha cell function in normal and diabetic subjects. Journal of Clinical Investigation. https://doi.org/10.1172/jci106297

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.